These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 30347660)
1. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin. Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660 [TBL] [Abstract][Full Text] [Related]
2. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779 [TBL] [Abstract][Full Text] [Related]
3. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail. Lucas TM; Janaka SK; Stephens EB; Johnson MC PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757 [TBL] [Abstract][Full Text] [Related]
4. Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors. Christodoulopoulos I; Droniou-Bonzom ME; Oldenburg JE; Cannon PM Retrovirology; 2010 Jan; 7():4. PubMed ID: 20102634 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. Iwabu Y; Fujita H; Kinomoto M; Kaneko K; Ishizaka Y; Tanaka Y; Sata T; Tokunaga K J Biol Chem; 2009 Dec; 284(50):35060-72. PubMed ID: 19837671 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain. Gustin JK; Douglas JL; Bai Y; Moses AV J Biol Chem; 2012 Apr; 287(18):14837-50. PubMed ID: 22383521 [TBL] [Abstract][Full Text] [Related]
7. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions. Yoshida T; Koyanagi Y; Strebel K J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238 [TBL] [Abstract][Full Text] [Related]
8. Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu. Janaka SK; Lucas TM; Johnson MC J Virol; 2011 Nov; 85(22):11945-54. PubMed ID: 21917962 [TBL] [Abstract][Full Text] [Related]
9. β-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin. Blanchet FP; Mitchell JP; Piguet V Curr HIV Res; 2012 Jun; 10(4):307-14. PubMed ID: 22524179 [TBL] [Abstract][Full Text] [Related]
10. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. Lucas TM; Lyddon TD; Cannon PM; Johnson MC J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505 [TBL] [Abstract][Full Text] [Related]
11. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048 [TBL] [Abstract][Full Text] [Related]
12. Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. Tokarev AA; Munguia J; Guatelli JC J Virol; 2011 Jan; 85(1):51-63. PubMed ID: 20980512 [TBL] [Abstract][Full Text] [Related]
13. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release. Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310 [TBL] [Abstract][Full Text] [Related]
14. Lack of adaptation to human tetherin in HIV-1 group O and P. Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466 [TBL] [Abstract][Full Text] [Related]
15. BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Richard J; Prévost J; von Bredow B; Ding S; Brassard N; Medjahed H; Coutu M; Melillo B; Bibollet-Ruche F; Hahn BH; Kaufmann DE; Smith AB; Sodroski J; Sauter D; Kirchhoff F; Gee K; Neil SJ; Evans DT; Finzi A J Virol; 2017 Jun; 91(11):. PubMed ID: 28331088 [TBL] [Abstract][Full Text] [Related]
16. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes. Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785 [TBL] [Abstract][Full Text] [Related]
18. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts. Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564 [TBL] [Abstract][Full Text] [Related]
20. Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Dubé M; Bego MG; Paquay C; Cohen ÉA Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]